Vanda Pharmaceuticals
VNDA
#8376
Rank
C$0.44 B
Marketcap
C$7.35
Share price
-2.76%
Change (1 day)
13.19%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -C$0.23 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.21 Billion. In 2025 the company made an earning of -C$0.22 Billion a decrease over its 2024 earnings that were of -C$56.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.23 Billion5.18%
2025 -C$0.22 Billion271.79%
2024 -C$56.53 Million191.43%
2023 -C$19.4 Million-320.45%
2022 C$8.79 M-84.99%
2021 C$58.61 M54.8%
2020 C$37.86 M19.42%
2019 C$31.7 M4.93%
2018 C$30.21 M-228.6%
2017 -C$23.5 Million-8.98%
2016 -C$25.82 Million-53.79%
2015 -C$55.87 Million-30.18%
2014 -C$80.01 Million173.08%
2013 -C$29.3 Million-25.33%
2012 -C$39.24 Million163.61%
2011 -C$14.89 Million-221.15%
2010 C$12.28 M-124.53%
2009 -C$50.09 Million-29.44%
2008 -C$70.99 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$91.35 Million170.55%
2005 -C$33.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.11 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.94 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.72 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.26 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.28 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.34 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$3.9 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA